Trials / Completed
CompletedNCT01316679
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 87 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Specific urine proteases or groups of these enzymes can be reliable biomarkers and an effective gauge of response to therapy in patients with hepatocellular carcinoma.
Conditions
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2011-03-16
- Last updated
- 2017-04-12
Source: ClinicalTrials.gov record NCT01316679. Inclusion in this directory is not an endorsement.